New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 12, 2012
06:36 EDTONCYOncolytics Biotech appoints Kirk Look to CFO position
Oncolytics Biotech announced the appointment of Kirk Look to the role of CFO. Look has served as Oncolytics' Controller since 2003 and has been the CFO of Oncolytics Biotech U.S. Inc. since 2009.
News For ONCY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 2, 2015
06:38 EDTONCYOncolytics Biotech announces receipt of Orphan Drug Designatoin for REOLYSIN
Subscribe for More Information
06:37 EDTONCYOncolytics Biotech receives ODD from FDA for Reolysin
Subscribe for More Information
February 18, 2015
06:41 EDTONCYOncolytics Biotech completes enrollment of randomized Phase II study of REOLYSIN
Subscribe for More Information
06:37 EDTONCYOncolytics Biotech completes enrollment in Phase II colorectal cancer study
Subscribe for More Information
February 17, 2015
06:40 EDTONCYOncolytics Biotech receives ODD from FDA for REOLYSIN
Subscribe for More Information
06:36 EDTONCYOncolytics Biotech granted Orphan Drug Designation for REOLYSIN by FDA
Oncolytics Biotech announced that the FDA has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of pancreatic cancer. REOLYSIN is Oncolytics' proprietary isolate of the reovirus. Its primary mode of activity is to infect and selectively target tumours with activating Ras pathway mutations and/or over-expressions of Ras pathway elements including, amongst others, EGFR, BRAF and KRAS.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use